L712-0005 Screening compound: N-(2-chlorophenyl)-4-{2-[2-(trifluoromethyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}tetrahydro-1(2H)-pyrazinecarboxamide

L712-0005 Screening compound: N-(2-chlorophenyl)-4-{2-[2-(trifluoromethyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}tetrahydro-1(2H)-pyrazinecarboxamide
L712-0005 Screening compound: N-(2-chlorophenyl)-4-{2-[2-(trifluoromethyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}tetrahydro-1(2H)-pyrazinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L712-0005
N-(2-chlorophenyl)-4-{2-[2-(trifluoromethyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}tetrahydro-1(2H)-pyrazinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L712-0005

Molecular Formula

C20H20ClF3N6O (C20 H20 ClF3 N6 O)

Compound Name

N-(2-chlorophenyl)-4-{2-[2-(trifluoromethyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}tetrahydro-1(2H)-pyrazinecarboxamide

IUPAC name

N-(2-chlorophenyl)-4-{2-[2-(trifluoromethyl)-3H-imidazo[45-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide

SMILES

O=C(Nc(cccc1)c1Cl)N1CCN(CCn2c3ncccc3nc2C(F)(F)F)CC1

InChI

InChI=1S/C20H20ClF3N6O/c21-14-4-1-2-5-15(14)27-19(31)29-11-8-28(9-12-29)10-13-30-17-16(6-3-7-25-17)26-18(30)20(22,23)24/h1-7H,8-13H2,(H,27,31)

InChI Key

VTOVGLTUOSVLSC-UHFFFAOYSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

452.87

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.171

Distribution Coefficient, logD

3.169

Water Solubility, LogSw

-3.32

Polar Surface Area

48.614

Acid Dissociation Constant (pKa)

12.14

Base Dissociation Constant (pKb)

4.91

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.00

L712-0005 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L712-0005 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L712-0005?
Check Price and Availability of L712-0005, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L712-0005 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L712-0005
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L712-0005
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L712-0005 available by request